Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albrecht Leo

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Biochemical Journal|June 7, 2002
Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in plateletsPeter Wonerow, Achim Obergfell, Jonathan I Wilde, et al.
Cancers|June 10, 2022
Early Development of Ubiquitous Acanthocytosis and Extravascular Hemolysis in Lung Cancer Patients Receiving AlectinibJulia Kunz, Christiane Wiedemann, Heidrun Grosch, et al.
International Journal of Cancer|May 9, 2024
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignanciesMaike Janssen, Albrecht Leo, Cornelia Wolf, et al.
European Journal of Haematology|September 7, 2004
Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphomaEugen Leo, Lars Scheuer, Ingo G H Schmidt-Wolf, et al.
Transplantation|May 20, 2015
Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific ImmunoadsorptionLuis E Becker, Daniela Siebert, Caner Süsal, et al.
Atherosclerosis. Supplements|August 27, 2019
Effectiveness of different immunoadsorption columns for anti-A/B antibody depletionClaudius Speer, Florian Kälble, Luiza Pego da Silva, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 20, 2019
Outcomes and complications following ABO-incompatible kidney transplantation performed after desensitization by semi-selective immunoadsorption - a retrospective studyClaudius Speer, Florian Kälble, Christian Nusshag, et al.
Transplantation|March 3, 2012
ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorptionChristian Morath, Luis Eduardo Becker, Albrecht Leo, et al.
Trials|October 7, 2020
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trialMaike Janssen, Ulrike Schäkel, Carine Djuka Fokou, et al.
Nature Cancer|December 29, 2022
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trialClaudia M Denkinger, Maike Janssen, Ulrike Schäkel, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Biochemical Journal|June 7, 2002
Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in plateletsPeter Wonerow, Achim Obergfell, Jonathan I Wilde, et al.
Cancers|June 10, 2022
Early Development of Ubiquitous Acanthocytosis and Extravascular Hemolysis in Lung Cancer Patients Receiving AlectinibJulia Kunz, Christiane Wiedemann, Heidrun Grosch, et al.
International Journal of Cancer|May 9, 2024
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignanciesMaike Janssen, Albrecht Leo, Cornelia Wolf, et al.
European Journal of Haematology|September 7, 2004
Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphomaEugen Leo, Lars Scheuer, Ingo G H Schmidt-Wolf, et al.
Transplantation|May 20, 2015
Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific ImmunoadsorptionLuis E Becker, Daniela Siebert, Caner Süsal, et al.
Atherosclerosis. Supplements|August 27, 2019
Effectiveness of different immunoadsorption columns for anti-A/B antibody depletionClaudius Speer, Florian Kälble, Luiza Pego da Silva, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 20, 2019
Outcomes and complications following ABO-incompatible kidney transplantation performed after desensitization by semi-selective immunoadsorption - a retrospective studyClaudius Speer, Florian Kälble, Christian Nusshag, et al.
Transplantation|March 3, 2012
ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorptionChristian Morath, Luis Eduardo Becker, Albrecht Leo, et al.
Trials|October 7, 2020
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trialMaike Janssen, Ulrike Schäkel, Carine Djuka Fokou, et al.
Nature Cancer|December 29, 2022
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trialClaudia M Denkinger, Maike Janssen, Ulrike Schäkel, et al.
Pageof 2